Industries > Pharma > Global Anaesthesia & Respiratory Devices Market Report 2019-2029

Global Anaesthesia & Respiratory Devices Market Report 2019-2029

Analysis by Product (Anesthesia Devices, Respiratory Devices), Plus Company and Country Analysis and Forecasts

PUBLISHED: 05 June 2019
PAGES: 134
PRODUCT CODE: PHA0429
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0429 Categories: , Tag:

Market Definition:
• Respiratory care devices are majorly used in diagnosing and treating respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. The use of these devices leads to better patient care, helping patients suffering acute and chronic respiratory diseases.
• Anesthesia devices are used during surgical procedures to control conditions such as pain, breathing, blood pressure, blood flow, and heart rate & rhythm. When anesthesia is used in patients, loss of sensation or awareness is experienced.

Market Overview and Trends
• Respiratory devices account for the largest share in this market; primarily due to their wide usage among the three consumer segments (healthcare institutions, home healthcare and transport) as compared to anesthesia devices; which have limited usage amongst the end-users.
• Initially, anesthesia and respiratory devices were designed and developed for operating rooms. However, with increase in awareness amongst the masses and advances in technology, these devices have found a place in post-operative care units, delivery rooms and critical care units; thereby increasing their demand.
• Advances in technology have spurred the market growth. Manufacturers are focusing on the aspect of portability of these devices; along with the addition of connectivity features to it. These have helped in seamless data transfer and expedited the treatment process.

Market Dynamics:

Factors Influencing the Market Growth:
• Growing cases of respiratory diseases, rapid urbanization, rapid growth in the number of surgical procedures, growing population, growth in geriatric population, and increase in tobacco consumption are the factors that are driving the growth of anesthesia and respiratory devices market.
• Innovations in the field of respiratory care devices and extended levels of governmental support in approving these devices add to the market growth.
• Rapidly growing demand for therapeutic devices in homecare settings and significant increase in the healthcare expenditures are other factors that offer lucrative growth opportunities for the market.
• Rising incidence of respiratory diseases such as obtrusive sleep apnea (OSA) and chronic obstructive pulmonary diseases (COPD); along with aging population are amongst the major factors influencing market growth for respiratory devices

Factors Restraining the Market Growth:
• High costs associated to installation and maintenance of anesthesia & respiratory devices may limit the market expansion.

Market Segmentation 2019-2029:
The anesthesia & respiratory devices market is segmented on the product, and geography.

Product
• Anesthesia Devices Market, 2019-2029:

• Anesthesia Machines Market, 2019-2029
– Anesthesia Workstations Market, 2019-2029
– Anesthesia Delivery Machines Market, 2019-2029
– Anesthesia Ventilators Market, 2019-2029
– Anesthesia Monitors Market, 2019-2029

• Anesthesia Disposables Market, 2019-2029
– Anesthesia Masks Market, 2019-2029
– Anesthesia Accessories Market, 2019-2029

• Respiratory Devices Market, 2019-2029

• Respiratory Devices Market, 2019-2029
– Humidifiers Market, 2019-2029
– Nebulizers Market, 2019-2029
– Oxygen Concentrators Market, 2019-2029
– Positive Airway Pressure Devices Market, 2019-2029
– Reusable Resuscitators Market, 2019-2029
– Ventilators Market, 2019-2029
– Respiratory Inhalers Market, 2019-2029

• Respiratory Disposables Market, 2019-2029
– Disposable Oxygen Masks Market, 2019-2029
– Resuscitators Market, 2019-2029
– Tracheostomy Tubes Market, 2019-2029
– Oxygen Cannula Market, 2019-2029

• Respiratory Measurement Devices Market, 2019-2029
– Pulse Oximetry Systems Market, 2019-2029
– Capnographs Market, 2019-2029
– Spirometers Market, 2019-2029
– Peak Flow Meters Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the anesthesia & respiratory devices market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
• The market for anesthesia and respiratory devices is fragmented with major players accounting for about 50% of the market.

Major Market Players:
GE Healthcare, Covidien, Draegerwerk AG, Teleflex Inc., Philips Healthcare, Acutronic Medical Systems AG, Airsep Corp, Alung Technologies Inc, Amsino International Inc, Astrazeneca, Bomimed Inc, Carefusion Corp, Consort Medical Plc, Convatec Inc, Fisher & Paykel Healthcare Ltd, Intersurgical Ltd, Lma International N.V., Getinge Group, Masimo Corp, Oridion Medical 1987 Ltd, Penlon Ltd, Philips Healthcare, Resmed Inc, Smiths Medical, And Teleflex Inc.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia & Respiratory Devices Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia & Respiratory Devices Market Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category